- Home
- KYMR vs AGYS Comparison
KYMR vs AGYS Comparison
Compare KYMR & AGYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- AGYS
- Stock Information
- Founded
- KYMR 2015
- AGYS 1963
- Country
- KYMR United States
- AGYS United States
- Employees
- KYMR N/A
- AGYS N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- AGYS EDP Services
- Sector
- KYMR Health Care
- AGYS Technology
- Exchange
- KYMR Nasdaq
- AGYS Nasdaq
- Market Cap
- KYMR 2.1B
- AGYS 2.4B
- IPO Year
- KYMR 2020
- AGYS N/A
- Fundamental
- Price
- KYMR $33.45
- AGYS $71.45
- Analyst Decision
- KYMR Buy
- AGYS Strong Buy
- Analyst Count
- KYMR 13
- AGYS 5
- Target Price
- KYMR $56.69
- AGYS $133.00
- AVG Volume (30 Days)
- KYMR 695.8K
- AGYS 402.3K
- Earning Date
- KYMR 05-01-2025
- AGYS 05-12-2025
- Dividend Yield
- KYMR N/A
- AGYS N/A
- EPS Growth
- KYMR N/A
- AGYS N/A
- EPS
- KYMR N/A
- AGYS 0.79
- Revenue
- KYMR $47,072,000.00
- AGYS $263,572,999.00
- Revenue This Year
- KYMR $44.93
- AGYS $17.25
- Revenue Next Year
- KYMR N/A
- AGYS $20.76
- P/E Ratio
- KYMR N/A
- AGYS $90.55
- Revenue Growth
- KYMR N/A
- AGYS 15.53
- 52 Week Low
- KYMR $29.07
- AGYS $71.37
- 52 Week High
- KYMR $53.27
- AGYS $142.64
- Technical
- Relative Strength Index (RSI)
- KYMR 44.68
- AGYS 27.86
- Support Level
- KYMR $31.54
- AGYS $72.72
- Resistance Level
- KYMR $31.66
- AGYS $82.23
- Average True Range (ATR)
- KYMR 2.31
- AGYS 3.27
- MACD
- KYMR 0.37
- AGYS 0.40
- Stochastic Oscillator
- KYMR 51.20
- AGYS 0.74
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About AGYS Agilysys Inc.
Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.